The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta‐analysis of observational studies-Reference-Cited by-同舟云学术

The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta‐analysis of observational studies

Published:2019-06-28 Issue:10 Volume:20 Page:1494-1503
ISSN:1467-7881
Container-title:Obesity Reviews
language:en
Short-container-title:Obesity Reviews

Author:

Hidayat Khemayanto¹^ORCID,Du Xuan¹,Wu Meng‐Jiao¹,Shi Bi‐Min¹

Affiliation:

1. Department of Endocrinology and MetabolismThe First Affiliated Hospital of Soochow University Suzhou China

Funder

Suzhou Municipal Science and Technology Bureau

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/obr.12885

Reference79 articles.

1. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

2. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

3. The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study

4. Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis

5. Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin resistance, bone health, and fracture risk;Osteoporosis International;2024-09-12

2. The association of type 2 diabetes‐related characteristics with fracture risk at different sites;Diabetes, Obesity and Metabolism;2024-09-02

3. Metformin-mediated effects on mesenchymal stem cells and mechanisms: proliferation, differentiation and aging;Frontiers in Pharmacology;2024-08-13

4. Qianggu concentrate: unlocking bone protection power via antioxidative SIRT1/NRF2/HO-1 pathways in type 2 diabetic osteoporosis;Frontiers in Pharmacology;2024-08-08

5. Impact of diabetes on the risk of subsequent fractures in 92,600 patients with an incident hip fracture: A Danish nationwide cohort study 2004–2018;Bone;2024-07